Key facts
- This page summarizes Lewis H. Titterton Jr.'s Form 4 filing for Anixa Biosciences Inc (ANIX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Jul 2026, 18:19.
Lewis H. Titterton Jr. - 20 Jul 2026 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)
- Reporting relationship
- Director
- Issuer ticker
- ANIX
- Reported as of
- 20 Jul 2026
- Net transaction value
- +$41,640
- SEC form
- 4
- Accepted by SEC
- 20 Jul 2026, 18:19:30 UTC
- Prior SEC filing
- 16 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lewis H. Titterton, Jr.
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Lewis H. Titterton Jr. filed Form 4 for Anixa Biosciences Inc (ANIX) on 20 Jul 2026.
Change
- Previous filing in this sequence was filed on 16 Jul 2026.
- Current net transaction value: +$41,640.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001499254
Primary reporting owner
Titterton Lewis H jr
- Relationship
- Director
- Address
- C/O ANIXA BIOSCIENCES, INC., 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE
- Signature
- /s/ Lewis H. Titterton, Jr.
- Signature date
- 20 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ANIX
transaction
Common Stock
Purchase
- Transaction value
- $41,640
- Shares
- +12,000
- Change %
- +1.2%
- Price
- $3.47
- Shares after
- 986,967
- Date
- 20 Jul 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.